|
|
|
2004 Neurotech Leaders Forum
October 4-5, 2004
Agenda
Day One: Neurotech Start-Up Intensive Course
This half-day event is targeted at early-stage neurotechnology firms and research professionals contemplating launching a neurotech start-up. Conference faculty will offer tutorial courses in preparing a business plan, conducting market and competitive research, and locating sources of funding specific to the neurotechnology industry.
| 12:00-1:00 |
Registration, Terra Room |
| 1:00-2:15 |
Selling Your Business Plan to VCs
Glenn Cornett, Senior Financial Editor, Neurotech
Reports
This session offers specific and practical advice on preparing a
set of initial materials, including executive summary, investor presentation, and financial model,
that will attract attention from venture capital firms. It includes examples of items that have made the difference between funding and no funding decisions. The presenter will also discuss how to find the most appropriate VC firm and how to arrange a meeting with the key person at the firm. |
| 2:15-3:30 |
Neurotechnology Market Fundamentals
James Cavuoto, Editor and Publisher, Neurotech Reports
This session gives attendees an overview of the neurotechnology market, with discussion of overall size, market segments, growth rates, competition, and key players. It will also include discussion of the various markets for neurological diseases and disorders. |
| 3:30-4:00 |
Refreshment Break |
| 4:00-5:30 |
One-on-One Mentoring Sessions
In these personalized sessions, each participant will have an opportunity to conduct a "dry-run" of a business plan presentation to a venture capital firm. Actual VC professionals and Neurotech Reports editors will be on hand to offer confidential and specific feedback on your business plan, market concept, or ideas so that you'll be better prepared for real-life funding opportunities.
|
| 5:30-7:00 |
Cocktail Reception, Sponsored by ANS, Club Lounge (10th Floor)
|
| |
|
Day Two: Neurotech Industry Sessions
This full-day conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are working to grow this new industry.
| 8:30-9:00 |
Registration and Coffee, Plaza I Ballroom |
| 9:00-9:15 |
Introduction |
| 9:15-9:45 |
Keynote Address: Building a Neurotechnology Company
Chris Chavez, President and CEO, Advanced Neuromodulation Systems, Inc. |
| 9:45-10:15 |
Neurotechnology Industry Update
James Cavuoto, Editor and Publisher, Neurotech Reports
This session will provide attendees with an up-to-date look at the neurotechnology industry, including discussion of deals, merger and acquisition activity, and venture capital funding that has occurred in the last year. |
| 10:15-10:30 |
Coffee Break, Sponsored by Neurometrix, Inc.
|
| 10:30-11:15 |
Reimbursement and Regulatory Affairs Panel
Glenn Cornett, Senior Financial Editor, Neurotech Reports, Moderator
Joe Schulman, President, Alfred Mann Foundation
Terri Zmina, Manager of Business Development, NDI Medical
Everett Shockley, Assistant Vice-President, Life Sciences, Chubb Group
This session will explore the regulatory and reimbursement issues confronting neurotechnology firms. Panelists from neurostimulation firms and government representatives will discuss ways of streamlining the approval process.
|
| 11:15-12:00 |
Commercialization Outlook Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Sam Hall, Financial Analyst, Citigroup SmithBarney
Andrew Merickel, Attorney, Knobbe Martens Olson & Bear
Gail Schechter, BioIntelligence
This session will explore the commercialization issues that neurotechnology firms confront when bringing a new product to market. It will include a discussion of collaborative agreements with larger life science firms as well as strategies for maximizing the value of your patent portfolio. |
| 12:00-1:30 |
Luncheon, Plaza II
Jennifer French, Executive Director, Society to Increase Mobility |
| 1:30-3:00 |
Entrepreneur Panel
Chris Berka, CEO, Advanced Brain Monitoring Inc.
Timothy Surgenor, CEO, Cyerkinetics, Inc.
Vince Owens, CEO, Texcel Medical Systems, LLC
Jeff Gagnon, Product Marketing Manager, Enpath Medical Inc.
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
| 3:00-3:15 |
Refreshment Break |
| 3:15-4:00 |
New Technologies Panel
Warren Grill, Associate Professor, Duke University
Shai Gozani, Chairman and CEO, Neurometrix Inc.
Jason Harry, President, Afferent Corp.
This session looks at several new technology areas within the field of neurotechnology and explores the commericalization potential of each. Technologies covered include neural-silicon hybrid chips, magnetic stimulation systems, nanobiotechnology applications, and biomimetic microelectronics. |
| 4:00-5:00 |
Venture Capital Firms Perspective
Albert Cha, Vivo Ventures
Andrew Firlik, The Sprout Group
Wende Hutton, Canaan Partners
Kevin Wasserstein, Versant Ventures
In this wrap-up session, representatives from several key venture capital firms in the neurotechnology space will offer their feedback on the status of the industry and their impressions of the issues discussed during the day. |
| 5:00-6:30 |
Cocktail Reception, Sponsored by Cyberonics, Inc., Plaza II |
| |
|
|
